CHAMPIONS ONCOLOGY, INC. Capital Leases, Future Minimum Payments, Interest Included in Payments
CHAMPIONS ONCOLOGY, INC. (CSBR) had Capital Leases, Future Minimum Payments, Interest Included in Payments of $10.00 thousand as of 2019-01-31, per its 10-Q filed 2019-03-18.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments · last filed 2019-03-18
- 2019-01-31: Capital Leases, Future Minimum Payments, Interest Included in Payments $10.00K.
- 2018-10-31: Capital Leases, Future Minimum Payments, Interest Included in Payments $14.00K.
- 2018-07-31: Capital Leases, Future Minimum Payments, Interest Included in Payments $19.00K.
- 2018-04-30: Capital Leases, Future Minimum Payments, Interest Included in Payments $2.00K.
| Period end | Capital Leases, Future Minimum Payments, Interest Included in Payments |
|---|---|
| 2019-01-31 | $10.00K 10-Q · filed 2019-03-18 |
| 2018-10-31 | $14.00K 10-Q · filed 2018-12-17 |
| 2018-07-31 | $19.00K 10-Q · filed 2018-09-14 |
| 2018-04-30 | $2.00K 10-K · filed 2018-07-30 |
| 2018-01-31 | $3.00K 10-Q · filed 2018-03-19 |
| 2017-10-31 | $3.00K 10-Q · filed 2017-12-15 |
| 2017-07-31 | $4.00K 10-Q · filed 2017-09-14 |
| 2017-04-30 | $5.00K 10-K · filed 2017-07-28 |
| 2017-01-31 | $6.00K 10-Q · filed 2017-03-17 |
| 2016-10-31 | $7.00K 10-Q · filed 2016-12-14 |
| 2016-07-31 | $8.00K 10-Q · filed 2016-09-14 |
| 2016-04-30 | $9.00K 10-K · filed 2016-07-29 |
| 2016-01-31 | $10.00K 10-Q · filed 2016-03-16 |
| 2015-10-31 | $12.00K 10-Q · filed 2015-12-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |